InfiCure Bio was awarded Innovative Start up Phase II from Vinnova. This opens up an additional market segment for InfiCure Bio, since the grant will fund the validation of the N-IF and the NFL strains as models for NASH.

Read more about the granted project at

 https://www.vinnova.se/p/validering-av-nya-djurmodeller-for-effekttester-av-substanser-for-behandling-av-fettlever/